SYNE-CHF
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

SYNE-CHF Trademark

Serial Number: 97068213 • Registration: 6916219

SYNE-CHF is a trademark filed by Sensyne Health Group Limited on October 11, 2021. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Sensyne Health Group Limited (26 trademarks)

Schrödinger Building
Oxford, Oxfordshire OX44GE , GB

Entity Type: 99

Trademark Details

Filing Date

October 11, 2021

Registration Date

December 6, 2022

Published for Opposition

September 20, 2022

Goods & Services

Recorded and downloadable computer software for use by the healthcare and life sciences business sectors for analyzing patient and clinical trial data in order to support pharmaceutical research and development and to improve direct patient care by providing predictive models to aid physicians in stratifying patients and making appropriate medical interventions for their treatment through the use of algorithms

Designing and developing computer software containing algorithms for use by the healthcare and life sciences business sectors for the purpose of analyzing patient and clinical trial data in order to support pharmaceutical research and development and to improve direct patient care by providing predictive models to aid physicians in stratifying patients and making appropriate medical interventions for their treatment; Software as a Service (SAAS) services in the form of computer software for use by the healthcare and life sciences business sectors for the purpose of analyzing patient and clinical trial data in order to support pharmaceutical research and development and to improve direct patient care by providing predictive models to aid physicians in stratifying patients and making appropriate medical interventions for their treatment through the use of algorithms; Algorithms as a service (AAAS), namely, on-line, non-downloadable software containing algorithms from a cloud-based platform for the design of computer software and computer programming for third-parties in the healthcare and life sciences business sectors for the purpose of analyzing patient and clinical trial data to support pharmaceutical research and development and to improve direct patient care by providing predictive models to aid physicians in stratifying patients and making appropriate medical interventions for their treatment

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 6, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 6, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 20, 2022 NPUB
PUBLISHED FOR OPPOSITION
Sep 20, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 31, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 17, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 16, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 16, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 16, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 16, 2022 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 8, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 8, 2022 CRFA
ASSIGNED TO LIE
Jul 7, 2022 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jun 22, 2022 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
May 26, 2022 GNS2
INQUIRY TO SUSPENSION E-MAILED
May 26, 2022 GNSI
SUSPENSION INQUIRY WRITTEN
May 26, 2022 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 26, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 26, 2021 GNSL
SUSPENSION LETTER WRITTEN
Nov 26, 2021 CNSL
ASSIGNED TO EXAMINER
Nov 14, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 2, 2021 NWOS
NEW APPLICATION ENTERED
Oct 14, 2021 NWAP